The BBC needs to make tough decisions due to the sustained financial pressures facing the organisation and must make savings of £500 million by 2028 ...

EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with ...

The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in ...

The future of insulation and hot water is here with a revolutionary water heater. Heat pumps are among the most ...

Buyers who got into Latitude Margaritaville Watersound early locked in a home price, but the developer's own fee disclosure ...

Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of ...

Admilparant 60 mg met the ALOFT-IPF primary end point, significantly improving FVC change vs placebo at 52 weeks in ...

Exercise affects far more than muscle, but its molecular effects vary across the body. By mapping changes across 22 tissues ...

Disc Medicine (IRON) posted strong APOLLO Phase 3 bitopertin results in EPP/XLP and plans an end-2026 NDA resubmission.

It Started with Yukichi Fukuzawa's ReskillingThe catalyst was a historical discussion about Yukichi Fukuzawa's ...

Anavex Life Sciences Corp. is cut from Strong Buy to Sell after FDA/EMA setbacks. Click to read this latest AVXL stock update ...

Chanel has sold its majority stake in the CDMO to Motion Equity Partners, while the founding CEO and management team retain a ...